Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cardioxyl Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT01096043
First received: March 22, 2010
Last updated: April 13, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
No publications provided by Cardioxyl Pharmaceuticals, Inc

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):